A little over a year ago, Medtronic brought in a complete outsider to reinvigorate a company whose biggest divisions were slowing down. Omar Ishrak is known for having engineered a small miracle at GE when Jack Welch installed him to run the ultrasound division in the company. Ishrak transformed the business — a business that […]
Medtronic’s Ken Riff sees the writing on the wall. The largest medical device company will not remain on top by simply doing what it has done all along: sell its products to hospitals where physicians implant patients with its life-saving or life-sustaining technology. The current focus on keeping people well and lowering healthcare costs necessarily […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Last week, Medtronic (NYSE:MDT) announced that one untested, yet promising therapy that it is developing had been accepted by a U.S. Food and Drug Administration pilot program meant to provide early feasibility testing of innovative medical devices. In fact, the Minnesota medical device maker’s stent graft to treat thoracic aortic aneurysms was one of nine devices chosen […]
Medtronic (NYSE:MDT) announced on Thursday that a stent graft to treat thoracic aortic aneurysms is one of nine devices part of a pilot program at the U.S. Food and Drug Administration aimed to help establish clinical and safety profiles for novel devices. As a result of this, Medtronic’s Valiant Mona LSA system developed to repair a descending thoracic aortic […]
Medtronic’s Paradigm Veo After having introduced an advanced diabetes treatment device to European and international patients in 2009, Medtronic (MDT) announced Friday that it has filed an application with the U.S. Food and Drug Administration that will bring the same therapy to the U.S. market. With this submission, the FDA will review for the first […]
Many believe that the panacea to the global plague of Type I diabetes is the development of an artificial pancreas. Medtronic (NYSE:MDT) has been on a quest to develop such a device: a small, portable closed-loop system comprising a continuous glucose monitor, an insulin pump capable of delivering precise amounts of insulin and a computer […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Medtronic CEO Omar Ishrak believes that increasing collaboration and integration will occur in the U.S. healthcare system, irrespective of how the Supreme Court rules in June. The U.S. Supreme Court is weighing several issues tied to President Barack Obama’s healthcare reform law, including whether the individual mandate requiring all Americans to buy insurance is constitutional […]
Regenerative medicine company Tengion (NASDAQ:TNGN) has always planned to take its novel tissue generating technology as far as early-stage clinical studies before finding a partner to finance later-stage work. The company’s lead program treating patients who have had their bladder removed is expected to finish phase 1 enrollment by year’s end. A preclinical kidney program […]
Medtronic (NYSE:MDT) is taking a restructuring charge of $87 million to account for layoffs in its Twin Cities location, the company reported Tuesday in its fourth quarter financial report. Roughly 220 positions have already been cut in its home state, and another 30 will lose their jobs in Minnesota. Those 250 job cuts are part […]
Medtronic (NYSE:MDT) may be the leader in the treatment of uncontrolled hypertension using electric stimulation, but now the question is for how long. The Minnesota medical device company was the first to commercialize this innovative therapy when it bought Ardian and its Symplicity Catheter Renal Denervation System in 2010 for an upfront $800 million. The […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
In a short news release issued Wednesday afternoon, Medtronic (NYSE:MDT) disclosed that the U.S. Department of Justice has closed its civil and criminal investigation into the company’s former blockbuster and controversial product Infuse. The investigation launched more than three years ago was into whether Medtronic illegally promoted the off-label use of the bone growth product. A spokesman […]
When it comes to commercialization efforts of renal denervation therapy, St. Jude Medical (NYSE:STJ) is behind Medtronic (NYSE:MDT). But St. Jude Medical is hoping that slow and steady may still win the race in the quest to use this novel treatment in patients whose high blood pressure is not controlled by medication. The device maker announced […]
Life science current events this week include J&J and MDT's contrasting acquisition strategies, the transcatheter valve replacement market and cardiovascular disease medical device companies.
Anyone who is even slightly aware of the dynamics of the medical device industry knows that Medtronic (NYSE:MDT) and Edwards Lifesciences (NYSE:EW) are not exactly the best of friends. The Minnesota behemoth and its smaller California rival have engaged in bitter legal wrangling over intellectual property and patents. Especially with respect to the transcatheter aortic […]
Johnson and Johnson’s (NYSE:JNJ) CEO Alex Gorsky is apparently shopping around for medical device companies to boost sagging sales in its Cardiovascular Division. A Bloomberg story highlights how some analysts believe companies like St. Jude Medical and Edwards Lifesciences could be good acquisition targets. J&J’s strategy of growing through acquisitions appears to contrast with the […]